Amedisys Inc Stock News

Even a good year for stocks has its share of high-flyers that have turned into losers — or buying opportunities.

COLD, ENR, KSU, FSTR, and AMED have been added to the Zacks Rank #5 (Strong Sell) List on November 26, 2021.

COLD, ENR, KSU, FSTR, and AMED have been added to the Zacks Rank #5 (Strong Sell) List on November 26, 2021.

Wall Street analysts forecast that Amedisys, Inc. (NASDAQ:AMED) will post sales of $555.84 million for the current fiscal quarter, according to Zacks. Seven analysts have issued estimates for Amedisys earnings. The highest sales estimate is $567.10 million and the lowest is $550.60 million. Amedisys posted sales of $550.71 million in the same quarter last year, []

AMED, CSII, DVA, GFF, and LTRX have been added to the Zacks Rank #5 (Strong Sell) List on November 19, 2021.

BATON ROUGE, La., Nov. 19, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high acuity care services, today announced that Paul

BATON ROUGE, La., Nov. 19, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high acuity care services, today announced that Paul B. Kusserow, Chairman and Chief Executive Officer, Chris Gerard, President and Chief Operating Officer and Scott Ginn, Executive Vice President and Chief Financial Officer will present at the Stephens Annual Investment Conference on December 3 rd at 10:00 am Eastern.

AMED, CSII, DVA, GFF, and LTRX have been added to the Zacks Rank #5 (Strong Sell) List on November 19, 2021.

BATON ROUGE, La., Nov. 19, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high acuity care services, today announced that Paul B.

Wall Street analysts expect Amedisys, Inc. (NASDAQ:AMED) to report earnings of $1.17 per share for the current quarter, Zacks reports. Seven analysts have issued estimates for Amedisys earnings. The highest EPS estimate is $1.25 and the lowest is $1.13. Amedisys posted earnings of $1.49 per share in the same quarter last year, which would suggest []

Related Stocks: AMED , BFAM , COUP , DAR , GO , LFUS , APPN , CCCS , SWIM , FA , WSO , ROLL , STMP , OUT , LSTR , PRLB , PLUG , TPIC ,

DBMR has added a new report titled Unskilled Home Healthcare Market with data Tables for historical and forecast years represented with Chats & Graphs spread through Pages with easy to understand detailed analysis. The credible report comprises of the market

BLMN, AMED, HL, LGIH, and PLMR have been added to the Zacks Rank #5 (Strong Sell) List on November 5, 2021.

BATON ROUGE, La., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and higher acuity care services, today announced that Paul

Amedisys (AMED) reports better-than-expected earnings for the third quarter on strong growth in the Home Health segment.